Identification of plasma proteins associated with oesophageal cancer chemotherapeutic treatment outcomes using SWATH-MS-Reference-Cited by-同舟云学术

Identification of plasma proteins associated with oesophageal cancer chemotherapeutic treatment outcomes using SWATH-MS

Published:2022-08 Issue: Volume:266 Page:104684
ISSN:1874-3919
Container-title:Journal of Proteomics
language:en
Short-container-title:Journal of Proteomics

Author:

Guo Naici,Minas Giorgos,Synowsky Silvia A.,Dunne Margaret R.,Ahmed Hasnain,McShane Rhiannon,Bhardwaj Anshul,Donlon Noel E.,Lorton Cliona,O'Sullivan Jacintha,Reynolds John V.,Caie Peter D.,Shirran Sally L.,Lynch Andy G.,Stewart Alan J.,Arya Swati

Funder

Wellcome Trust

Health Research Board

Tenovus

University of St Andrews

Publisher

Elsevier BV

Subject

Biochemistry,Biophysics

Reference69 articles.

1. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017;Lancet Gastroenterol. Hepatol.,2020

2. Global burden of oesophageal and gastric cancer by histology and subsite in 2018;Arnold;Gut,2020

3. Predicting the future burden of esophageal cancer by histological subtype: international trends in incidence up to 2030;Arnold;Am. J. Gastroenterol.,2017

4. The prognostic value of the lymph node in oesophageal adenocarcinoma; incorporating clinicopathological and immunological profiling;Donlon;Cancers,2021

5. Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: evidence of a radiation and chemotherapy dose response;Geh;Radiother. Oncol.,2006

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIST1H2BK predicts neoadjuvant-chemotherapy response and mediates 5-fluorouracil resistance of gastric cancer cells;Translational Oncology;2024-08

2. Multi-omics approaches for biomarker discovery in predicting the response of esophageal cancer to neoadjuvant therapy: A multidimensional perspective;Pharmacology & Therapeutics;2024-02